Advancing the Science

Mayo Clinic Medical Science Blog

Items Tagged ‘Dr. Robert Jenkins’

February 28th, 2017

More women eligible for Herceptin, benefit uncertain

By Nicole Brudos Ferrara nicoleferrara

Updated guidelines underscore need to identify the most optimal candidates for HER2-directed therapy. Changes to HER2 testing guidelines for breast cancer in 2013 significantly increased the number of patients who test positive for HER2 breast cancer, Mayo Clinic researchers have found. The researchers published their HER2 breast cancer study results online July 25, 2016, in […]

View full entry

Tags: breast cancer, Cancer Research, Dr. Robert Jenkins, Forefront, HER2, Journal of Clinical Oncology, Mayo Clinic Cancer Center


Contact Us · Privacy Policy